BHVN Q3 2018 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$55M

Net Income

-$61M

EPS (Diluted)

$-1.53

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$195M

Total Liabilities

$129M

Stockholders' Equity

$66M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$55M	-$40M	-38.8%
Net Income	-$61M	-$43M	-43.2%